Partial
Mostly Aligned
Patient Risk:
Low
Summary
Overall partial alignment. The AI claims include non-labeled site use (skin) and OTC status, which are not supported by the provided label. Supported elements include mechanism of action and certain mucous-membrane indications (mouth/pharynx). There is a direct contradiction regarding mucous membranes (claimed limitation vs. label allowing mucous membranes). Several dosing/administration specifics are missing from the label and AI claims. Notable omissions and ambiguities exist.
Category Scores
Accurate Statements
Lidocaine spray blocks nerve signals in the applied area.
MOA specifies lidocaine stabilizes the neuronal membrane and inhibits impulse conduction (local anesthetic action).
Lidocaine spray provides topical anesthesia of mucous membranes of the mouth and pharynx.
Indication states topical anesthesia of irritated or inflamed mucous membranes of the mouth and pharynx.
Common uses include sore throat.
Sore throat involves mucous membranes of the pharynx; within indicated use.
Common uses include mouth ulcers.
Mucous membranes of the mouth; mouth ulcers fall within indicated use.
Common uses include cold sores.
Cold sores involve mucous membranes; within mouth/pharynx indication.
Allergic reactions (rash, swelling, breathing issues)—stop use and seek help.
Hypersensitivity is contraindicated; safety guidance aligns with stopping use on hypersensitivity.
Indication includes topical anesthesia of irritated or inflamed mucous membranes of the mouth and pharynx.
Directly drawn from INDICATIONS AND USAGE section.
Unsupported Statements
Lidocaine spray is FDA-approved for numbing skin and mucous membranes to relieve minor pain.
Label indicates mucous membranes of the mouth and pharynx; no explicit skin indication or explicit FDA-approval phrasing for this claim.
Lidocaine spray is an over-the-counter topical anesthetic.
OTC status not stated in provided label sections.
It targets superficial pain on intact skin or accessible mucous membranes.
Label covers mucous membranes of mouth and pharynx; no explicit indication for intact skin.
Do not use for deep wounds.
No wound-depth restriction in provided sections.
Do not use on areas larger than 10% of body surface.
No body-surface-area restriction in provided sections.
Do not use near eyes.
Not stated in provided sections.
Shake the can.
Not in provided label sections.
Hold 6-12 inches away.
Not in provided label sections.
Spray 1-3 short bursts per area.
Not in provided label sections.
Wait 1-2 minutes for numbing.
Not in provided label sections.
Reapply every 1-2 hours if needed.
Not in provided label sections.
Do not exceed 3-4 times daily.
Not in provided label sections.
Wash hands after use.
Not in provided label sections.
Test on a small patch first for allergies.
Not in provided label sections.
Overuse leading to methemoglobinemia (rare).
Methemoglobinemia appears in drug-interaction context, not as a direct overuse warning in provided sections.
Not for kids under 2 without doctor advice.
Pediatric Use discusses dosage reductions but does not specify an under-2 restriction in provided sections.
Pregnant or breastfeeding users should consult a doctor.
Label discusses pregnancy use as clearly-needed; nursing guidance is cautionary but explicit consult-a-doctor statement is not shown.
Avoid if you have liver issues.
No liver-specific contraindication in provided sections.
Avoid if you have heart problems.
No heart-disease contraindication in provided sections.
Do not combine with other numbing products.
Not in provided label sections.
Persistent pain, signs of infection (pus, fever), or no relief after use should see a doctor; could signal serious issues like nerve damage or infection.
Not in provided sections.
For chronic pain (e.g., arthritis, neuropathy), oral meds or prescriptions work better.
Not in provided sections.
Alternatives: Benzocaine sprays as a topical alternative.
Not in provided sections.
Alternatives: Hydrocortisone cream for inflammation.
Not in provided sections.
Alternatives: Capsaicin for nerve pain.
Not in provided sections.
Alternatives (non-drug): Ice packs.
Not in provided sections.
Alternatives: NSAIDs like ibuprofen for broader relief.
Not in provided sections.
Prescription upgrades: Lidocaine patches (Lidoderm) or stronger creams for severe cases.
Not in provided sections.
Contradictions
Low
AI Statement
Do not use on mucous membranes unless specified.
Label Reference
INDICATIONS AND USAGE
Important Omissions
Explicit dosing/dosage instructions, administration technique details, and age-based restrictions beyond general pediatric-use language.
Importance:
Moderate
OTC status and regulatory labeling context for consumer guidance.
Importance:
Moderate
Storage and handling specifics.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
Label emphasizes precautions to avoid high plasma levels; under recommended use, risk is low.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Suggested Improvement
Align statements with label scope (mouth/pharynx mucous membranes only), remove or qualify skin-related indications, clearly state dosing/administration details and OTC status if evaluating consumer guidance; resolve contradictions about mucous membrane usage.